Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 32283153)

Published in J Infect on April 11, 2020

Authors

Xiaowei Fang1, Qing Mei1, Tianjun Yang1, Lei Li2, Yinzhong Wang1, Fei Tong1, Shike Geng3, Aijun Pan4

Author Affiliations

1: Department of Intensive Care Unit, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province 230001, China.
2: Department of Infectious Disease, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province 230001, China.
3: Department of Intensive Care Unit, The Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui Province 230001, China.
4: Department of Intensive Care Unit, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province 230001, China; Department of Intensive Care Unit, The Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui Province 230001, China. Electronic address: aijunpan868@sina.com.

Articles cited by this

Clinical progression of patients with COVID-19 in Shanghai, China. J Infect (2020) 6.61